1.1299 -0.01 (-0.89%)
After hours: 1:07PM EST
|Bid||1.1300 x 1200|
|Ask||1.1400 x 34100|
|Day's Range||1.1000 - 1.1793|
|52 Week Range||0.2000 - 4.3000|
|Beta (5Y Monthly)||0.54|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug. 07, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.75|
Continued progress on oncology and COVID-19 vaccine programsOver $117 million of cash and short-term investments DURHAM, NC / ACCESSWIRE / November 9, 2020 / Heat Biologics, Inc.
Some Heat Biologics, Inc. (NASDAQ:HTBX) shareholders are probably rather concerned to see the share price fall 49...
New patent covers ICOS T cell co-stimulation in combination with Heat's proprietary gp96 platformDURHAM, NC / ACCESSWIRE / October 7, 2020 / Heat Biologics, Inc.